| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.066 | 0.6 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |